021-51111890
购物车（）
sales@molnova.cn
TM5441
CAS No. 1190221-43-2
TM5441 ( TM-5441;BMS790052; EBP883 )
产品货号. M17864 CAS No. 1190221-43-2
TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor 1 (PAI-1).
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥389 | 有现货 |
|
| 5MG | ￥640 | 有现货 |
|
| 10MG | ￥988 | 有现货 |
|
| 25MG | ￥2130 | 有现货 |
|
| 50MG | ￥3993 | 有现货 |
|
| 100MG | ￥5678 | 有现货 |
|
| 500MG | ￥11826 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TM5441
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor 1 (PAI-1).
-
产品描述TM-5441, also known as EBP 883 and BMS-790052, is a potent plasminogen activator inhibitor-1 (PAI-1). TM-5441 inhibits several tumor cell lines with IC50 values between 9.7 and 60.3 μM. TM5441 protects against high-fat diet-induced obesity and adipocyte injury in mice.
-
同义词TM-5441;BMS790052; EBP883
-
通路Others
-
靶点Other Targets
-
受体PAI-1
-
研究领域——
-
适应症——
化学信息
-
CAS Number1190221-43-2
-
分子量428.83
-
分子式C21H17ClN2O6
-
纯度98%
-
溶解度DMSO : ≥ 300 mg/mL; 699.59 mM
-
SMILESO=C(O)c3cc(Cl)ccc3NC(=O)COCC(=O)Nc1cccc(c1)c2ccco2
-
化学全称5-chloro-2-(2-(2-((3-(furan-3-yl)phenyl)amino)-2-oxoethoxy)acetamido)benzoic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Placencio VR, et al. Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity. PLoS One. 2015 Jul 24;10(7):e0133786.
产品手册
关联产品
-
Tyroserleutide hydro...
Tyroserleutide hydrochloride is a small molecule tripeptide isolated from the degradation product of pig spleen, which can inhibit tumor growth in vivo and in vitro.
-
THIP
THIP has a strong affinity for the δ subunit of GABAA receptors. THIP is a functionally selective GABAAR ligand, agonistic to α4β1δ, α4β3δ, and weakly antagonistic to αβγ and α4β2δ GABAARs.
-
AdTx1
Selective, high affinity, non-competitive α1A adrenoceptor antagonist (Ki = 0.35 nM). Exhibits no significant activity against a range of other GPCRs, including α2A, β1 and β2 adrenoceptors. Antagonizes effects of phenylephrine on isolated rabbit prostate muscle in vitro and on intra-urethral pressure in rats.
